Amdocs (DOX) shareholders back board, higher dividend and ESPP shares

Rhea-AI Filing Summary

Amdocs Limited held its 2026 Annual General Meeting, where shareholders elected ten directors to serve until the 2027 meeting, with each nominee receiving strong support. All management proposals on the agenda were approved.

Shareholders approved an amendment to the 2023 Employee Share Purchase Plan to add 2,200,000 ordinary shares reserved for issuance. They also increased the quarterly cash dividend rate from $0.527 per share to $0.569 per share.

In addition, shareholders approved the Company’s consolidated financial statements for the fiscal year ended September 30, 2025, and ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending September 30, 2026, authorizing the Audit Committee to set its remuneration.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2026

Commission File Number 1-14840

AMDOCS LIMITED

Hirzel House, Smith Street,

St. Peter Port, Island of Guernsey, GY1 2NG

Amdocs, Inc.

625 Maryville Centre Drive, Suite 200, Saint Louis, Missouri 63141

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

FORM 20-F ☒     FORM 40-F ☐

Submission of Matters to a Vote of Security Holders.

Voting Results.

At the 2026 Annual General Meeting of Shareholders of Amdocs Limited (the “Company”) held on January 30, 2026, the proposals listed below were submitted to a vote of the Company’s shareholders. The proposals are described in the Company’s proxy statement for the 2026 Annual General Meeting of Shareholders.

Proposal 1 – The election of ten nominees to the Company’s Board of Directors each for a term of one year.

The 10 nominees named in the proxy statement were elected to serve as directors until the Company’s 2027 Annual General Meeting of Shareholders. Information as to the vote on each director standing for election is provided below:

Nominee		Votes For		Votes Against		Votes Abstaining		Broker Non-Votes
Eli Gelman		90,931,235		1,842,964		30,314		0
Robert A. Minicucci		78,702,515		14,069,326		32,672		0
Adrian Gardner		90,150,567		2,618,368		35,578		0
Rafael de la Vega		91,864,535		905,738		34,240		0
John A. MacDonald		90,722,524		2,046,082		35,907		0
Yvette Kanouff		92,518,196		250,096		36,221		0
Sarah Ruth Davis		90,754,510		2,014,230		35,773		0
Amos Genish		91,281,451		1,487,770		35,292		0
Véronique Morali		92,721,466		46,851		36,196		0
Shuky Sheffer		92,091,552		681,130		31,831		0

Proposal 2 – The approval of an amendment to the Amdocs Limited 2023 Employee Share Purchase Plan to increase the number of ordinary shares reserved for issuance thereunder by 2,200,000 shares.

The shareholders approved the amendment to the Amdocs Limited 2023 Employee Share Purchase Plan. The voting results were as follows:

Votes For		Votes Against		Votes Abstaining		Broker Non-Votes
92,639,496		129,017		36,000		0

Proposal 3 – The approval of an increase in the dividend rate under the Company’s quarterly cash dividend program from $0.527 per share to $0.569 per share.

The shareholders approved an increase in the dividend rate under the Company’s quarterly cash dividend program from $0.527 per share to $0.569 per share. The voting results were as follows:

Votes For		Votes Against		Votes Abstaining		Broker Non-Votes
92,765,545		12,349		26,619		0

Proposal 4 – The approval of the Company’s Consolidated Financial Statements for the fiscal year ended September 30, 2025.

The shareholders approved the Company’s Consolidated Financial Statements for the fiscal year ended September 30, 2025. The voting results were as follows:

Votes For		Votes Against		Votes Abstaining		Broker Non-Votes
92,354,184		12,620		437,709		0

Proposal 5 – The ratification and approval of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2026, and until the next annual general meeting, and authorization of the Audit Committee of the Board of Directors to fix the remuneration of such independent registered public accounting firm in accordance with the nature and extent of its services.

The shareholders ratified and approved the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2026, and until the next annual general meeting, and authorized the Audit Committee of the Board of Directors to fix the remuneration of such independent registered public accounting firm in accordance with the nature and extent of its services. The voting results were as follows:

Votes For		Votes Against		Votes Abstaining		Broker Non-Votes
86,657,903		6,117,165		29,445		0

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AMDOCS LIMITED
By:		/s/ Matthew E. Smith
		Matthew E. Smith
		Secretary and Authorized Signatory

Date: January 30, 2026

FAQ

What did Amdocs (DOX) shareholders approve at the 2026 annual meeting?

Shareholders approved all proposals, including electing ten directors, amending the 2023 Employee Share Purchase Plan, raising the quarterly dividend, approving fiscal 2025 consolidated financial statements, and ratifying Ernst & Young LLP as independent auditor for the fiscal year ending September 30, 2026.

How much did Amdocs (DOX) increase its quarterly dividend per share?

The quarterly cash dividend was increased from $0.527 per share to $0.569 per share. This reflects a higher recurring cash return to shareholders under the company’s regular dividend program, as approved by shareholders at the 2026 Annual General Meeting.

What change was made to the Amdocs 2023 Employee Share Purchase Plan?

Shareholders approved an amendment to the 2023 Employee Share Purchase Plan to increase the number of ordinary shares reserved for issuance by 2,200,000 shares. This expands the pool of stock available for employee participation in the plan going forward.

Which directors were elected to Amdocs’ Board at the 2026 meeting?

Ten nominees were elected for one-year terms, including Eli Gelman, Robert A. Minicucci, Adrian Gardner, Rafael de la Vega, John A. MacDonald, Yvette Kanouff, Sarah Ruth Davis, Amos Genish, Véronique Morali, and Shuky Sheffer.

Did Amdocs (DOX) shareholders approve the fiscal 2025 financial statements?

Yes. Shareholders approved the Company’s consolidated financial statements for the fiscal year ended September 30, 2025. This vote confirms shareholder acceptance of the reported results and disclosures for that fiscal year as presented by management.

Who is Amdocs’ independent auditor for the year ending September 30, 2026?

Shareholders ratified and approved Ernst & Young LLP as Amdocs’ independent registered public accounting firm for the fiscal year ending September 30, 2026, and authorized the Board’s Audit Committee to determine its remuneration based on the nature and extent of its services.